SRPT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

24.9

Margin Of Safety %

Put/Call OI Ratio

0.84

EPS Next Q Diff

-2.38

EPS Last/This Y

11.96

EPS This/Next Y

-2.1

Price

16.81

Target Price

22.67

Analyst Recom

2.74

Performance Q

-7.28

Upside

-174.3%

Beta

0.22

Ticker: SRPT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	SRPT	20.4	0.81	1.38	111821
2026-04-24	SRPT	20.27	0.84	1.14	116858
2026-04-27	SRPT	20.97	0.84	0.22	111439
2026-04-28	SRPT	21.05	0.82	0.26	112771
2026-04-29	SRPT	20.67	0.81	0.30	113755
2026-04-30	SRPT	20.88	0.81	0.21	114299
2026-05-01	SRPT	21.49	0.81	0.17	114584
2026-05-04	SRPT	22.03	0.81	0.32	110887
2026-05-05	SRPT	21.79	0.81	0.38	112655
2026-05-06	SRPT	22.88	0.80	1.02	113423
2026-05-07	SRPT	20.79	0.83	0.84	116476
2026-05-08	SRPT	19.96	0.83	0.11	117628
2026-05-11	SRPT	19.4	0.84	0.63	114241
2026-05-12	SRPT	19.12	0.84	0.26	114763
2026-05-13	SRPT	18.85	0.82	0.39	115261
2026-05-14	SRPT	18.67	0.81	0.68	115719
2026-05-15	SRPT	17.53	0.79	0.99	116167
2026-05-18	SRPT	17	0.87	0.71	103117
2026-05-19	SRPT	16.65	0.85	1.08	104014
2026-05-20	SRPT	17.11	0.85	0.72	105156
2026-05-21	SRPT	16.97	0.85	0.48	105848
2026-05-22	SRPT	16.81	0.84	0.85	105884
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	SRPT	20.41	130.6	783.1	4.14
2026-04-24	SRPT	20.27	130.6	782.3	3.99
2026-04-27	SRPT	20.98	130.6	786.3	3.99
2026-04-28	SRPT	21.07	130.6	787.4	3.99
2026-04-30	SRPT	20.87	130.6	786.3	3.99
2026-05-01	SRPT	21.48	130.6	789.8	3.99
2026-05-04	SRPT	22.03	130.6	792.8	3.99
2026-05-05	SRPT	21.79	130.6	791.5	3.99
2026-05-06	SRPT	23.03	130.6	799.9	3.99
2026-05-07	SRPT	20.79	130.6	785.9	3.99
2026-05-08	SRPT	19.95	-47.2	-	3.92
2026-05-11	SRPT	19.41	-47.2	-	3.92
2026-05-12	SRPT	19.13	-72.2	-	3.92
2026-05-13	SRPT	18.85	-72.2	-	3.92
2026-05-14	SRPT	18.67	-72.2	-	3.92
2026-05-15	SRPT	17.54	-72.2	-	4.82
2026-05-18	SRPT	17.01	-72.2	-	4.82
2026-05-19	SRPT	16.65	-72.2	-	4.82
2026-05-20	SRPT	17.13	-75.8	-	4.83
2026-05-21	SRPT	16.95	-75.8	-	4.83
2026-05-22	SRPT	16.81	-75.8	-	4.83
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	SRPT	-0.37	-1.16	25.87
2026-04-24	SRPT	-0.37	-1.16	25.87
2026-04-27	SRPT	-0.37	-0.53	25.47
2026-04-28	SRPT	-0.37	-0.53	25.47
2026-04-29	SRPT	-0.37	-0.53	25.47
2026-04-30	SRPT	-0.37	-0.53	25.47
2026-05-01	SRPT	-0.37	-0.53	25.47
2026-05-04	SRPT	-0.37	-0.71	25.47
2026-05-05	SRPT	-0.37	-0.71	25.47
2026-05-06	SRPT	-0.37	-0.71	25.47
2026-05-07	SRPT	-0.37	-0.71	25.47
2026-05-08	SRPT	-0.37	-0.71	25.47
2026-05-11	SRPT	-0.37	-0.81	25.33
2026-05-12	SRPT	-0.37	-0.81	24.92
2026-05-13	SRPT	-0.37	-0.81	24.92
2026-05-14	SRPT	-0.37	-0.81	24.92
2026-05-15	SRPT	-0.37	-0.81	24.92
2026-05-18	SRPT	-0.37	-0.08	24.92
2026-05-19	SRPT	-0.37	-0.08	24.92
2026-05-20	SRPT	-0.37	-0.08	24.92
2026-05-21	SRPT	-0.37	-0.08	24.90
2026-05-22	SRPT	-0.37	-0.08	24.90
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.88

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.5

Insider Transactions

-0.37

Institutional Transactions

-0.08

Beta

0.22

Average Sales Estimate Current Quarter

361

Average Sales Estimate Next Quarter

367

Fair Value

20.75

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.3

Max Drawdown 5-Year %

-92.7

Target Price

22.67

P/E

Forward P/E

17.67

PEG

P/S

0.81

P/B

1.18

P/Free Cash Flow

18.13

EPS

-0.96

Average EPS Est. Cur. Y

4.83

EPS Next Y. (Est.)

2.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2.94

Relative Volume

0.64

Return on Equity vs Sector %

-22.7

Return on Equity vs Industry %

-7.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.84

EBIT Estimation

◆ SRPT Healthcare

$16.80

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

21/25

Volume

9/15

Valuation

20/20

TP/AR

2/10

Options

4/10

RSI

32.7

Range 1M

3.4%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

15/30

Estimates

4/20

Inst/Vol

0/15

Options

2/10

EPS Yr

148.5%

EPS NY

-72.5%

52W%

19.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +69.7% upside

Quality

6/30

Valuation

22/30

Growth

13/25

Stability

6/10

LT Trend

4/5

Upside

+69.7%

Quality

MoS

23%

Sarepta Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 835

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

SRPT

Latest News

—

Caricamento notizie per SRPT…

stock quote shares SRPT – Sarepta Therapeutics, Inc. Stock Price stock today

news today SRPT – Sarepta Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SRPT – Sarepta Therapeutics, Inc. yahoo finance google finance

stock history SRPT – Sarepta Therapeutics, Inc. invest stock market

stock prices SRPT premarket after hours

ticker SRPT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SRPT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y